Current Neuropharmacology, current C Cu Cur Curr BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,,- 4 10 0 0 0 0 0
187 187 187 1 18 187 187 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
1570-159X/07 $50.00+.00 1570-159x/07 1 15 157 1570 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 -/$.. 5 6 0 1 0 0 0
©2007 Bentham ©2007 © ©2 ©20 ©200 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 . 1 10 0 1 0 0 0
Allosteric Modulators allosteric A Al All Allo BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
F. Gasparini f. F F. F. F. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .*. 3 10 0 0 0 0 1
Novartis Institutes novartis N No Nov Nova BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,-.,,-,;. 10 10 0 0 0 0 1
Hofmann-La Roche, hofmann-la H Ho Hof Hofm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -,,,-,, 7 7 0 0 0 0 1
Abstract: The abstract: A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 :(-)-.- 7 9 0 0 0 0 1
tors have tors t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 10 0 0 0 0 1
glutamate receptors glutamate g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
role and role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
various nervous various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,,' 4 9 0 0 0 0 1
search for search s se sea sear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
the receptor the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
most recent most m mo mos most BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 10 0 0 0 0 1
Since their since S Si Sin Sinc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 []- 3 9 0 0 0 0 1
sequent cloning sequent s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 [,],- 5 9 0 0 0 0 1
tamate receptor tamate t ta tam tama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 ()- 3 8 0 0 0 0 1
ward the ward w wa war ward BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 no 0 9 0 0 0 0 1
role of role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
patho-physiology. To patho-physiology. p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -.(-) 5 9 0 0 0 0 1
been cloned been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 -,- 3 8 0 0 0 0 1
ogy and ogy o og ogy ogy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 - 1 9 0 0 0 0 1
tered into tered t te ter tere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 (-)[]. 6 9 0 0 0 0 1
family 3 family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 - 1 9 0 0 0 0 1
ognition N-terminal ognition o og ogn ogni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -- 2 8 0 0 0 0 1
regions that regions r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 -- 2 9 0 0 0 0 1
lular loops lular l lu lul lula BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 []. 3 9 0 0 0 0 1
extracellular ligand extracellular e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -- 2 9 0 0 0 0 1
bi-lobed structure bi-lobed b bi bi- bi-l BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -(-) 4 9 0 0 0 0 1
open or open o op ope open BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 - 1 9 0 0 0 0 1
nist, respectively nist, n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 ,[]., 5 10 0 0 0 0 1
brain functional brain b br bra brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
exist as exist e ex exi exis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 []. 3 9 0 0 0 0 1
for all for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
agents identified agents a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 [] 2 9 0 0 0 0 1
receptor by receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 9 0 0 0 0 1
N-terminal domain, n-terminal N N- N-t N-te BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 -,. 3 9 0 0 0 0 1
named competitive named n na nam name BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 9 0 0 0 0 1
to Glutamate, to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 , 1 9 0 0 0 0 1
amino-acid functionality, amino-acid a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 -, 2 9 0 0 0 0 1
competitive ligands competitive c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 9 0 0 0 0 1
membranes by membranes m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 .,- 3 8 0 0 0 0 1
pounds have pounds p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 , 1 9 0 0 0 0 1
blood-brain-barrier. A blood-brain-barrier. b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 --. 3 9 0 0 0 0 1
small molecular small s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 ,, 2 7 0 0 0 0 1
LY404039 [53] ly404039 L LY LY4 LY40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 []/ 3 8 0 0 0 0 1
receptors, are receptors, r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,, 2 9 0 0 0 0 1
model [36,37] model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 [,] 3 8 0 0 0 0 1
potential anti-panic potential p po pot pote BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 -[]. 4 4 0 0 0 0 1
The difficulty the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 9 0 1 0 0 1
quate drug-like quate q qu qua quat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -- 2 9 0 1 0 0 1
portant element portant p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 10 0 1 0 0 1
compound classes compound c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 0 1 0 0 1
DISCOVERY DISCOVERY discovery D DI DIS DISC BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 10 0 1 0 0 1
The identification the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 8 0 1 0 0 1
linked with linked l li lin link BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 0 1 0 0 1
terization of terization t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 . 1 10 0 1 0 0 1
For the for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 ,-, 3 9 0 1 0 0 1
two cellular two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 8 0 1 0 0 1
intracellular Ca intracellular i in int intr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 (.). 4 8 0 1 0 0 1
*Address correspondence *address * *A *Ad *Add BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 *- 2 10 0 1 0 0 1
cal Research cal c ca cal cal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 6 ,,-.,,- 7 9 0 1 0 0 1
4002 Basel, 4002 4 40 400 4002 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 6 ,;:;:; 6 9 0 1 0 0 1
E-mail: fabrizio.gasparini@novartis.com e-mail: E E- E-m E-ma BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 -:.@. 5 5 0 1 0 0 1
For the for F Fo For For BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 0 0 0 0 1
Gi type gi G Gi Gi Gi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 -,--- 5 10 0 0 0 0 1
ing and ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 7 - 1 9 0 0 0 0 1
oped (Fig. oped o op ope oped BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (.). 4 2 0 0 0 0 1
The development the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 9 0 0 0 0 1
to a to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
chemical libraries chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
no structural no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 9 0 0 0 0 1
negative allosteric negative n ne neg nega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 () 2 9 0 0 0 0 1
modulators (PAM). modulators m mo mod modu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 (). 3 2 0 0 0 0 1
A number a A A A A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 7 no 0 8 0 0 0 0 1
action and action a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
published [13,14,20,44,45,50,55]. published p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 [,,,,,,]., 10 9 0 0 0 0 1
the most the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 - 1 9 0 0 0 0 1
tion of tion t ti tio tion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 . 1 8 0 0 0 0 1
GROUP I group G GR GRO GROU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
mGluR1 NAM mglur1 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
CPCCOEt (1) cpccoet C CP CPC CPCC BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 () 2 8 0 1 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 []. 3 9 0 1 0 0 1
investigate the investigate i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,, 2 9 0 1 0 0 1
limited potency limited l li lim limi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (),- 4 8 0 1 0 0 1
availability and availability a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 10 0 1 0 0 1
Nevertheless, CPCCOEt nevertheless, N Ne Nev Neve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ,- 2 9 0 1 0 0 1
and allowed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
located in located l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 [].- 4 8 0 1 0 0 1
pound, BAY36-7620 pound, p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,-() 4 9 0 1 0 0 1
the same the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 10 0 1 0 0 1
tive activity tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 [].- 4 9 0 1 0 0 1
has allowed has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 9 0 1 0 0 1
convulsant effect convulsant c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
memory task memory m me mem memo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ()[,]. 6 8 0 1 0 0 1
was later was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ., 2 8 0 1 0 0 1
various issues various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 9 0 1 0 0 1
terization using terization t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 10 0 1 0 0 1
of mGlu1 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
disorders. The disorders. d di dis diso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 .,- 3 9 0 1 0 0 1
cally active cally c ca cal call BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 8 ()[]. 5 9 0 1 0 0 1
JNJ16259685 is jnj16259685 J JN JNJ JNJ1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 1 8 no 0 9 0 1 0 0 1
3.2 and 3.2 3 3. 3.2 3.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 ..- 3 9 0 1 0 0 1
and human and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,., 3 9 0 1 0 0 1
of JNJ16259685 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 1 0 0 1
Together these together T To Tog Toge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 9 0 1 0 0 1
lent tool lent l le len lent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
therapeutics [25]. therapeutics t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 []..[]- 7 9 0 1 0 0 1
properties in properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
synergistic effects synergistic s sy syn syne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 ., 2 9 0 1 0 0 1
the effects the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 9 0 1 0 0 1
nists as nists n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
not on not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 1 0 0 1
on locomotor on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
cerebellar structures cerebellar c ce cer cere BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 9 0 1 0 0 1
188 Current 188 1 18 188 188 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 ,,.,. 5 10 1 0 1 1 0
Gasparini and gasparini G Ga Gas Gasp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 0 1 1 0
tolerance to tolerance t to tol tole BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,. 3 9 1 0 0 0 1
[61] described [61] [ [6 [61 [61] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 []- 3 9 1 0 0 0 1
esses, irrespective esses, e es ess esse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,-, 4 10 1 0 0 0 1
already at already a al alr alre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (./). 5 9 1 0 0 0 1
retention performance retention r re ret rete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
to locate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
These data these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
affects learning affects a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 0 0 0 1
information relatively information i in inf info BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 4 1 0 0 0 1
Another potent another A An Ano Anot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 - 1 9 1 1 0 0 1
is A-841720 is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -()[]. 6 8 1 1 0 0 1
mGluR1 receptors, mglur1 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 ,-- 3 9 1 1 0 0 1
mobilization, with mobilization, m mo mob mobi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,..,, 5 9 1 1 0 0 1
while showing while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 .- 2 9 1 1 0 0 1
neal injection neal n ne nea neal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 1 -' 2 9 1 1 0 0 1
adjuvant-induced inflammatory adjuvant-induced a ad adj adju BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 -(/)- 5 9 1 1 0 0 1
oiodoacetate-induced joint oiodoacetate-induced o oi oio oiod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 -(/).- 6 9 1 1 0 0 1
decreased mechanical decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 9 1 1 0 0 1
chronic constriction chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -() 3 9 1 1 0 0 1
models of models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (/,). 5 10 1 1 0 0 1
Electrophysiological studies electrophysiological E El Ele Elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 - 1 10 1 1 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 - 1 9 1 1 0 0 1
firing in firing f fi fir firi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 .,- 3 9 1 1 0 0 1
cant motor cant c ca can cant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 - 1 9 1 1 0 0 1
841720 also 841720 8 84 841 8417 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 1 - 1 9 1 1 0 0 1
Water Maze water W Wa Wat Wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 . 1 9 1 1 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 - 1 9 1 1 0 0 1
tor and tor t to tor tor BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 . 1 4 1 1 0 0 1
Taken together, taken T Ta Tak Take BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 , 1 10 1 0 0 0 1
effects in effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 - 1 9 1 0 0 0 1
may not may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 2 5 - 1 9 1 0 0 0 1
ment of ment m me men ment BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 . 1 8 1 0 0 0 1
mGluR1 PAM mglur1 m mG mGl mGlu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 no 0 10 1 0 0 0 1
Knoflach et knoflach K Kn Kno Knof BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 .[] 3 8 1 1 0 0 1
series, compounds series, s se ser seri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,,(.), 6 9 1 1 0 0 1
agonist-mediated responses agonist-mediated a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 -- 2 9 1 1 0 0 1
tor and tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 . 1 9 1 1 0 0 1
enhance the enhance e en enh enha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 1 1 0 0 1
cells recombinantely cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 1 1 0 0 1
which the which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 10 1 1 0 0 1
all three all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 1 1 0 0 1
of orthosteric of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .. 2 9 1 1 0 0 1
From the from F Fr Fro From BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 1 1 0 0 1
by an by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 - 1 9 1 1 0 0 1
tor and tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 .,- 3 9 1 1 0 0 1
tivity over tivity t ti tiv tivi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,,, 3 8 1 1 0 0 1
receptors whereas receptors r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 1 1 0 0 1
glutamate-induced activation glutamate-induced g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 -., 3 9 1 1 0 0 1
when tested when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 1 1 0 0 1
as positive as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,. 2 9 1 1 0 0 1
Furthermore, using furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 9 1 1 0 0 1
mutagenesis, Knoflach mutagenesis, m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,.[], 5 9 1 1 0 0 1
compounds interact compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 1 1 0 0 1
pocket compared pocket p po poc pock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ., 2 8 1 1 0 0 1
structurally different structurally s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 1 1 0 0 1
chemical derivatization chemical c ch che chem BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (,.) 4 8 1 1 0 0 1
Fig. (1). fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 .().. 5 10 1 0 0 0 1
Fig. (2). fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 .().. 5 10 1 1 0 0 1
[cAMP] determination [camp] [ [c [cA [cAM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 [] 2 10 1 1 0 0 1
GTP-γ-35 S gtp-γ-35 G GT GTP GTP- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 -- 2 10 1 1 0 0 1
AC AC ac A AC AC AC BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
= glutamate = = = = = BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
β β β β β β β BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
γ γ γ γ γ γ γ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
α i α α α α α BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GDP GDP gdp G GD GDP GDP BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GTP GTP gtp G GT GTP GTP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GTP-γ-35 S gtp-γ-35 G GT GTP GTP- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 -- 2 10 1 1 0 0 1
ATP ATP atp A AT ATP ATP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 no 0 8 1 1 0 0 1
cAMP cAMP camp c cA cAM cAMP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
[cAMP] determination [camp] [ [c [cA [cAM BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 [] 2 10 1 1 0 0 1
GTP-γ-35 S gtp-γ-35 G GT GTP GTP- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 -- 2 10 1 1 0 0 1
AC AC ac A AC AC AC BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
= glutamate = = = = = BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
β β β β β β β BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
γ γ γ γ γ γ γ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
α i α α α α α BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GDP GDP gdp G GD GDP GDP BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GTP GTP gtp G GT GTP GTP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
GTP-γ-35 S gtp-γ-35 G GT GTP GTP- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 -- 2 10 1 1 0 0 1
ATP ATP atp A AT ATP ATP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 no 0 8 1 1 0 0 1
cAMP cAMP camp c cA cAM cAMP BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 11 no 0 10 1 1 0 0 1
Allosteric Modulators allosteric A Al All Allo BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 1 1 1 0
Current Neuropharmacology, current C Cu Cur Curr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,.,. 5 10 0 1 1 0 0
was described was w wa was was BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 10 0 1 0 0 1
and 8, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 9 0 1 0 0 1
brane domain brane b br bra bran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 1 0 0 1
mGluR1 allosteric mglur1 m mG mGl mGlu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 []. 3 6 0 1 0 0 1
So far, so S So So So BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 , 1 10 0 1 0 0 1
mGlu1 receptor mglu1 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 , 1 9 0 1 0 0 1
on learning on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [,]- 4 9 0 1 0 0 1
hancement of hancement h ha han hanc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
could be could c co cou coul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 1 0 0 1
esses. esses. esses. e es ess esse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 1 0 1 0 0 1
mGluR5 NAM mglur5 m mG mGl mGlu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
2-methyl-6-(phenylethynyl)-pyridine (MPEP), 2-methyl-6-(phenylethynyl)-pyridine 2 2- 2-m 2-me BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 ---()-(),- 10 8 0 0 0 0 1
typical allosteric typical t ty typ typi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 []., 4 9 0 0 0 0 1
selective and selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
receptor expressed receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 9 0 0 0 0 1
quisqualate-stimulated phosphoinositide quisqualate-stimulated q qu qui quis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 -() 3 9 0 0 0 0 1
IC 50 ic I IC IC IC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
at other at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .' 2 9 0 0 0 0 1
MPEP acts mpep M MP MPE MPEP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 -. 2 9 0 0 0 0 1
large extent large l la lar larg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 1 - 1 10 0 0 0 0 1
expressing rat expressing e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,- 2 8 0 0 0 0 1
verse agonist verse v ve ver vers BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 []. 3 2 0 0 0 0 1
Using chimeras using U Us Usi Usin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
hmGluR1 and hmglur1 h hm hmG hmGl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 ,[]- 4 9 0 0 0 0 1
2-methyl-6-(3-methoxyphenyl)ethynyl pyridine 2-methyl-6-(3-methoxyphenyl)ethynyl 2 2- 2-m 2-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 ---(-)(-) 9 9 0 0 0 0 1
be determined be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -(),- 5 9 0 0 0 0 1
Ser-658 (TMIII) ser-658 S Se Ser Ser- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 -() 3 9 0 0 0 0 1
binding and binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 .- 2 9 0 0 0 0 1
versely, the versely, v ve ver vers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ,-- 3 9 0 0 0 0 1
sponding reciprocal sponding s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 10 0 0 0 0 1
mGlu1 receptor mglu1 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 []-- 4 9 0 0 0 0 1
affinity [40]. affinity a af aff affi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 [].- 4 9 0 0 0 0 1
ited by ited i it ite ited BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -[]-- 5 9 0 1 0 0 1
ethyl ester ethyl e et eth ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 3 5 (),- 4 9 0 1 0 0 1
mGluR1 antagonist mglur1 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
region of region r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 []. 3 10 0 1 0 0 1
and CPCCOEt and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
gion of gion g gi gio gion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 9 0 1 0 0 1
residues. Several residues. r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 1 0 0 1
the chemical the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 9 0 1 0 0 1
ized, among ized, i iz ize ized BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
characterized [5,57]. characterized c ch cha char BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 [,]. 4 3 0 1 0 0 1
The identification the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 (---()- 7 7 0 0 0 0 1
pyridine allowed pyridine p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
class of class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .-- 3 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -- 2 9 0 0 0 0 1
exhibit the exhibit e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
models seen models m mo mod mode BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 []. 3 3 0 0 0 0 1
Fenobam Fenobam fenobam F Fe Fen Feno BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo- fenobam F Fe Fen Feno BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 [-(-)-'-(,------ 16 8 0 0 0 0 1
1H-imidazole-2-yl)urea] (10) 1h-imidazole-2-yl)urea] 1 1H 1H- 1H-i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ---)](), 8 9 0 0 0 0 1
until recently until u un unt unti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 , 1 9 0 0 0 0 1
been demonstrated been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 - 1 9 0 0 0 0 1
iolytic-like activity. iolytic-like i io iol ioly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 -..- 4 8 0 0 0 0 1
Roche, Fenobam roche, R Ro Roc Roch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,(-) 4 9 0 0 0 0 1
at mGlu5 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 []. 3 9 0 0 0 0 1
a selective a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 7 - 1 9 0 0 0 0 1
tagonist acting tagonist t ta tag tago BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 - 1 9 0 0 0 0 1
methyl-6-phenylethynyl-pyridine (MPEP). methyl-6-phenylethynyl-pyridine m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ---().- 7 9 0 0 0 0 1
qualate-evoked intracellular qualate-evoked q qu qua qual BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 - 1 9 0 0 0 0 1
mGlu5 receptor mglu5 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 . 1 9 0 0 0 0 1
manner, similar manner, m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 ,- 2 9 0 0 0 0 1
ties, blocking ties, t ti tie ties BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 ,( 2 10 0 0 0 0 1
expressed cell expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 ).[]- 5 10 0 0 0 0 1
rat and rat r ra rat rat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 9 0 0 0 0 1
Fig. (3). fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 .().. 5 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
OH OH oh O OH OH OH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
O O o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
S S s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
S S s S S S S BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
mGluR1 NAMs mglur1 m mG mGl mGlu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
mGluR1 PAM mglur1 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
1, CPCCOEt 1, 1 1, 1, 1, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 , 1 7 0 1 0 0 1
2, BAY36-7620 2, 2 2, 2, 2, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 ,- 2 10 0 1 0 0 1
3, JNJ16259685 3, 3 3, 3, 3, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 , 1 10 0 0 0 0 1
(R199912) (R199912) (r199912) ( (R (R1 (R19 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 11 () 2 6 0 0 0 0 1
4, A841720 4, 4 4, 4, 4, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 , 1 10 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
6 6 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
7 7 7 7 7 7 7 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
190 Current 190 1 19 190 190 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 ,,.,. 5 10 0 0 1 0 0
Gasparini and gasparini G Ga Gas Gasp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 0 1 0 0
nM, respectively. nm, n nM nM, nM, BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,.[]- 5 9 0 1 0 0 1
mGlu5 receptors mglu5 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ., 2 9 0 1 0 0 1
binding site binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
robust anxiolytic-like robust r ro rob robu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
the stress-induced the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,,- 4 9 0 1 0 0 1
Seifter conflict seifter S Se Sei Seif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
minimum effective minimum m mi min mini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 /..,- 5 9 0 1 0 0 1
bam is bam b ba bam bam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
that Fenobam that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
The non-GABAergic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 9 0 1 0 0 1
anxiolytic activity anxiolytic a an anx anxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
ceptor antagonists ceptor c ce cep cept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
zodiazepines as zodiazepines z zo zod zodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 0 1 0 0 1
receptor antagonists receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
supported by supported s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 10 0 1 0 0 1
are at are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
efficacious in efficacious e ef eff effi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
standardized (Diazepam) standardized s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()[,]. 6 9 0 1 0 0 1
studies that studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 1 0 0 1
trum psychoneurotic trum t tr tru trum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
cognitive, dysphoric cognitive, c co cog cogn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,. 2 9 0 1 0 0 1
differentiated from differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
induced less induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 0 1 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
mGlu5 receptor mglu5 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 9 0 1 0 0 1
studies. studies. studies. s st stu stud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
mGluR5 PAM mglur5 m mG mGl mGlu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 no 0 10 0 1 0 0 1
In contrast in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 4 , 1 8 0 1 0 0 1
relatively few relatively r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 9 0 1 0 0 1
The first the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 9 0 1 0 0 1
ture and ture t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 9 0 1 0 0 1
and the and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 [].,(,'- 8 10 0 1 0 0 1
difluorobenzaldazine, 11, difluorobenzaldazine, d di dif difl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,,.), 5 9 0 1 0 0 1
induces a induces i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ().- 4 9 0 1 0 0 1
ingly, a ingly, i in ing ingl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 9 0 1 0 0 1
nistic activity nistic n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (,'-, 5 9 0 1 0 0 1
12, Fig. 12, 1 12 12, 12, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,.)., 5 9 0 1 0 0 1
chlorine for chlorine c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
with no with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,(,'-- 6 8 0 1 0 0 1
benzaldazine, 13, benzaldazine, b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,,.). 5 9 0 1 0 0 1
to demonstrate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
activation to activation a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 / 1 9 0 1 0 0 1
receptor ligands. receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 10 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
site to site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 1 0 0 1
after, two after, a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,,- 3 9 0 1 0 0 1
totypic compounds totypic t to tot toty BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ()() 4 8 0 1 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 [,]. 4 8 0 1 0 0 1
potent increase potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
human and human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
subtypes nor subtypes s su sub subt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 9 0 1 0 0 1
was seen was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
teric agonist teric t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 [] 2 8 0 1 0 0 1
a receptor a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 5 []. 3 9 0 1 0 0 1
the binding the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 []-[,] 6 9 0 1 0 0 1
whereas only whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 []- 3 8 0 1 0 0 1
methoxy-PEP-y [5] methoxy-pep-y m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 --[] 4 9 0 1 0 0 1
MPEP. Despite mpep. M MP MPE MPEP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ., 2 8 0 1 0 0 1
DFB nor dfb D DF DFB DFB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
vivo evaluation vivo v vi viv vivo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ., 2 9 0 1 0 0 1
the CDPPB the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
derivatives but derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
modulators [8]. modulators m mo mod modu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 []. 3 2 0 1 0 0 1
Fig. (4). fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 .().. 5 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
S S s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
H H h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
OH OH oh O OH OH OH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 6 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 6 0 1 0 0 1
NH NH nh N NH NH NH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
CN CN cn C CN CN CN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
8, MPEP 8, 8 8, 8, 8, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 6 0 1 0 0 1
9, MPEP 9, 9 9, 9, 9, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 6 0 1 0 0 1
10, Fenobam 10, 1 10 10, 10, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 10 0 1 0 0 1
mGluR5 NAMs mglur5 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
mGluR5 PAMs mglur5 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
11, DFB 11, 1 11 11, 11, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 10 0 1 0 0 1
14, CPPHA 14, 1 14 14, 14, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 10 0 1 0 0 1
15, CDPPB 15, 1 15 15, 15, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 10 0 1 0 0 1
12, DMeOB 12, 1 12 12, 12, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 10 0 1 0 0 1
13, DCB 13, 1 13 13, 13, BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 , 1 8 0 1 0 0 1
Allosteric Modulators allosteric A Al All Allo BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 1 1 0 0
Current Neuropharmacology, current C Cu Cur Curr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,.,. 5 10 0 1 1 0 0
In vivo, in I In In In BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 0 ,- 2 8 0 1 0 0 1
tive to tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 :- 2 9 0 1 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 0 1 0 0 1
(PPI) in (ppi) ( (P (PP (PPI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ()., 4 8 0 1 0 0 1
beneficial effect beneficial b be ben bene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -[]. 4 10 0 1 0 0 1
demonstrated for demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 1 0 0 1
mGluR5 allosteric mglur5 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 no 0 9 0 1 0 0 1
of these of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 6 0 1 0 0 1
GROUP II group G GR GRO GROU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 10 0 0 0 0 1
mGluR2 NAM mglur2 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 no 0 1 0 0 0 0 1
Since the since S Si Sin Sinc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 - 1 8 0 0 0 0 1
czewski et czewski c cz cze czew BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 .[].[]- 7 9 0 0 0 0 1
ment nor ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 no 0 9 0 0 0 0 1
date. These date. d da dat date BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 .(. 3 9 0 0 0 0 1
4) were 4) 4 4) 4) 4) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 )--[] 5 9 0 0 0 0 1
a rat a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 1 - 1 8 0 0 0 0 1
IC 50 ic I IC IC IC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 1 . 1 9 0 0 0 0 1
mGluR1, mGluR4, mglur1, m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 ,, 2 8 0 0 0 0 1
published for published p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 - 1 9 0 0 0 0 1
tors. Based tors. t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 ., 2 10 0 0 0 0 1
could be could c co cou coul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 8 0 0 0 0 1
and or and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 []. 3 4 0 0 0 0 1
mGluR2 PAM mglur2 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 no 0 10 0 0 0 0 1
Among all among A Am Amo Amon BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 8 0 0 0 0 1
II subtypes ii I II II II BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 no 0 10 0 0 0 0 1
development by development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 4 no 0 8 0 0 0 0 1
[36,37]. This [36,37]. [ [3 [36 [36, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 [,].() 6 8 0 0 0 0 1
have been have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
related disorders related r re rel rela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
their use their t th the thei BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 9 0 1 0 0 1
tors for tors t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 []. 3 10 0 1 0 0 1
principle with principle p pr pri prin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 1 0 0 1
mGluR2,3 subtypes mglur2,3 m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 , 1 9 0 1 0 0 1
devoid of devoid d de dev devo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 5 0 1 0 0 1
The search the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 1 0 0 1
structure, LY354740, structure, s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,,- 3 8 0 1 0 0 1
like properties like l li lik like BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
search for search s se sea sear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .,- 3 9 0 1 0 0 1
tional assays tional t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 8 0 1 0 0 1
allowed the allowed a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
modulators: the modulators: m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 :() 3 8 0 1 0 0 1
[19]. LY487379 [19]. [ [1 [19 [19] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 []. 3 8 0 1 0 0 1
class were class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
displacement of displacement d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 1 0 0 1
all known all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 1 0 0 1
selective for selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 1 0 0 1
including the including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 1 0 0 1
receptor. In receptor. r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .,- 3 9 0 1 0 0 1
cacy in cacy c ca cac cacy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (; 2 9 0 1 0 0 1
induced hyperthermia) induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 )-( 3 9 0 1 0 0 1
locomotor activity) locomotor l lo loc loco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 )[].- 5 8 0 1 0 0 1
scribed shortly scribed s sc scr scri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -(.) 4 8 0 1 0 0 1
[7,46,47,48]. In [7,46,47,48]. [ [7 [7, [7,4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [,,,]., 7 9 0 1 0 0 1
profile to profile p pr pro prof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
brain penetrable brain b br bra brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 5 ,(), 4 8 0 1 0 0 1
anti-psychotic effects anti-psychotic a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 -[,,,]. 7 7 0 1 0 0 1
Fig. (5). fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 .().. 5 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
S S s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
NMe 2 nme N NM NMe NMe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
S S s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
HN N hn H HN HN HN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 6 0 0 0 0 1
OH OH oh O OH OH OH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
HO HO ho H HO HO HO BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
16 16 16 1 16 16 16 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
mGluR2 NAMs mglur2 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
17 17 17 1 17 17 17 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
mGluR2 PAMs mglur2 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 1
LY487379, 18 ly487379, L LY LY4 LY48 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 , 1 10 0 1 0 0 1
19 19 19 1 19 19 19 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 2 0 1 0 0 1
20, BINA 20, 2 20 20, 20, BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 , 1 10 0 1 0 0 1
192 Current 192 1 19 192 192 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,.,. 5 10 0 1 1 0 0
Gasparini and gasparini G Ga Gas Gasp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 1 1 0 0
Taken together taken T Ta Tak Take BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 1 0 0 1
constitute a constitute c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 10 0 1 0 0 1
vention to vention v ve ven vent BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -,-. 4 9 0 1 0 0 1
GROUP III group G GR GRO GROU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
mGluR4, 6, mglur4, m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,,, 3 3 0 0 0 0 1
Compared to compared C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 8 0 0 0 0 1
the Group the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 1
negative modulators. negative n ne neg nega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .,- 3 8 0 0 0 0 1
pounds claimed pounds p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 (;) 3 8 0 0 0 0 1
been described. been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
selective allosteric selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
of 7 of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 1 0 0 0 0 1
mGluR4 PAM mglur4 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
For the for F Fo For For BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 ,, 2 8 0 0 0 0 1
PHCCC, 21 phccc, P PH PHC PHCC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 ,[],[] 6 9 0 0 0 0 1
as antagonist as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,. 2 9 0 0 0 0 1
MPEP, 8 mpep, M MP MPE MPEP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 , 1 9 0 0 0 0 1
very high very v ve ver very BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (-) 3 9 0 0 0 0 1
magnitude higher magnitude m ma mag magn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
the mGlu5 the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 2 0 0 0 0 1
In rat in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 2 ,.[]- 5 9 0 0 0 0 1
onstrate that onstrate o on ons onst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 no 0 10 0 0 0 0 1
mGluR modulation mglur m mG mGl mGlu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 no 0 9 0 0 0 0 1
nigra pars nigra n ni nig nigr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 (),- 4 10 0 0 0 0 1
rodegeneration and rodegeneration r ro rod rode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 ' 1 10 0 0 0 0 1
Disease. Unfortunately, disease. D Di Dis Dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 .,- 3 10 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 0 0 0 1
validation in validation v va val vali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 0 0 0 1
positive modulators. positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 10 0 0 0 0 1
of mGluR4 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 0 0 0 1
al. [30]. al. a al al. al. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 .[]. 4 1 0 0 0 0 1
mGluR7 PAM mglur7 m mG mGl mGlu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 no 0 10 0 1 0 0 1
As for as A As As As BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
suitable selective suitable s su sui suit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 1 0 0 1
study of study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .,- 3 10 0 1 0 0 1
acterization of acterization a ac act acte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 - 1 10 0 1 0 0 1
dependent functions dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 , 1 9 0 1 0 0 1
and responses and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 10 0 1 0 0 1
[6,32,35]. [6,32,35]. [6,32,35]. [ [6 [6, [6,3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 [,,]. 5 1 0 1 0 0 1
The recent the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 8 0 1 0 0 1
AMN082 (24, amn082 A AM AMN AMN0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 (,.) 4 9 0 1 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 []., 4 8 0 1 0 0 1
potently activate potently p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 9 0 1 0 0 1
tor with tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 . 1 10 0 1 0 0 1
addition, AMN082 addition, a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,(,-) 5 9 0 1 0 0 1
induced receptor induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 10 0 1 0 0 1
the other the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ., 2 8 0 1 0 0 1
orally bioavailable, orally o or ora oral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 10 0 1 0 0 1
level of level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 () 2 9 0 1 0 0 1
but not but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .- 2 9 0 1 0 0 1
strate that strate s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 no 0 9 0 1 0 0 1
pharmacotherapy of pharmacotherapy p ph pha phar BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 -. 2 8 0 1 0 0 1
CONCLUSIONS/OUTLOOK CONCLUSIONS/OUTLOOK conclusions/outlook C CO CON CONC BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 / 1 10 0 0 0 0 1
The ubiquitous the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 9 0 0 0 0 1
critical role critical c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 10 0 0 0 0 1
CNS. Next cns. C CN CNS CNS. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 .-,- 4 8 0 0 0 0 1
tabotropic glutamate tabotropic t ta tab tabo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,- 2 9 0 0 0 0 1
aptic transmission, aptic a ap apt apti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,. 2 9 0 0 0 0 1
small, the small, s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,-- 3 9 0 0 0 0 1
have become have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 9 0 0 0 0 1
modulators of modulators m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 . 1 9 0 0 0 0 1
chemistry that chemistry c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 9 0 0 0 0 1
ceptors through ceptors c ce cep cept BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 no 0 9 0 0 0 0 1
transmembrane signaling transmembrane t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 no 0 9 0 1 0 0 1
natural agonist natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 ., 2 9 0 1 0 0 1
illustrative in illustrative i il ill illu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 /- 2 9 0 1 0 0 1
teric modulators teric t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 no 0 9 0 1 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 .- 2 9 0 1 0 0 1
nation of nation n na nat nati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 7 , 1 9 0 1 0 0 1
approaches, has approaches, a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 , 1 9 0 1 0 0 1
roles of roles r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 9 0 1 0 0 1
behavior. From behavior. b be beh beha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 .,- 3 9 0 1 0 0 1
type selective type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 - 1 9 0 1 0 0 1
cebo controlled cebo c ce ceb cebo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 . 1 9 0 1 0 0 1
These developments these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 8 0 1 0 0 1
better treatments better b be bet bett BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 9 0 1 0 0 1
disorders that disorders d di dis diso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 , 1 10 0 1 0 0 1
anxiety disorders, anxiety a an anx anxi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 ,. 2 5 0 1 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 no 0 10 0 0 0 0 1
[1] [1] [1] [ [1 [1] [1] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 [] 2 0 0 0 0 0 1
Annoura, H., annoura, A An Ann Anno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ,.,,.,,.,,.,,.() 16 8 0 0 0 0 1
A novel a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 9 ,- 2 8 0 0 0 0 1
(hydroxyimino)cyclopropachromen-1a-carboxylates. Bioorg. (hydroxyimino)cyclopropachromen-1a-carboxylates. ( (h (hy (hyd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 ()--.... 8 8 0 0 0 0 1
Lett., 6, lett., L Le Let Lett BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 .,,-. 5 2 0 0 0 0 1
[2] [2] [2] [ [2 [2] [2] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 [] 2 0 0 0 0 0 1
Bergink, V., bergink, B Be Ber Berg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ,.,,..() 8 8 0 0 0 0 1
agonists in agonists a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 :.. 3 9 0 0 0 0 1
Clin. Psychopharmacol., clin. C Cl Cli Clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ..,,-. 6 4 0 0 0 0 1
[3] [3] [3] [ [3 [3] [3] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 [] 2 0 0 0 0 0 1
Carroll, F.Y., carroll, C Ca Car Carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ,..,,.,,..,,.,,.,,.,, 21 10 0 0 0 0 1
C., Antonicek, c., C C. C., C., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 .,,.,,.,,.,,..,,.() 19 9 0 0 0 0 1
BAY36-7620: a bay36-7620: B BA BAY BAY3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 -:-- 4 8 0 0 0 0 1
verse agonist verse v ve ver vers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ...,,-. 7 6 0 0 0 0 1
[4] [4] [4] [ [4 [4] [4] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 [] 2 0 0 0 0 0 1
Conn, P.J., conn, C Co Con Conn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ,..,,..(). 10 8 0 0 0 0 1
glutamatereceptors. Ann. glutamatereceptors. g gl glu glut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 .....,,-. 9 7 0 0 0 0 1
Fig. (6). fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 .().. 5 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
OH OH oh O OH OH OH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
H H h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
22, SIB1893 22, 2 22 22, 22, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 , 1 10 0 1 0 0 1
mGluR4 PAMs mglur4 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 1
21, PHCCC 21, 2 21 21, 21, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 , 1 10 0 1 0 0 1
mGluR7 NAM mglur7 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
23 23 23 2 23 23 23 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
mGluR7 PAM mglur7 m mG mGl mGlu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 1
24, AMN082 24, 2 24 24, 24, BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 11 , 1 10 0 1 0 0 1
Allosteric Modulators allosteric A Al All Allo BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 1 1 0 0
Current Neuropharmacology, current C Cu Cur Curr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ,,.,. 5 10 0 1 1 0 0
[5] [5] [5] [ [5 [5] [5] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Cosford, N.D., cosford, C Co Cos Cosf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,.,,.,,..,, 18 9 0 1 0 0 1
J., Bristow, j., J J. J., J., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.,,.,,.,,.,,.,,., 20 9 0 1 0 0 1
Varney, M.A. varney, V Va Var Varn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..()-[(--,---)]-:- 19 9 0 1 0 0 1
tent and tent t te ten tent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 1 0 0 1
nist with nist n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ....,,-. 8 6 0 1 0 0 1
[6] [6] [6] [ [6 [6] [6] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Cryan, J.F., cryan, C Cr Cry Crya BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,.,,..,,. 21 10 0 1 0 0 1
(2003) Antidepressant (2003) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 ()- 3 9 0 1 0 0 1
III metabotropic iii I II III III BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ....,,-. 8 9 0 1 0 0 1
[7] [7] [7] [ [7 [7] [7] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Cube, R.V., cube, C Cu Cub Cube BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ,..,,..,,..,,..,,.., 20 8 0 1 0 0 1
Rowe, B.A., rowe, R Ro Row Rowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,.,,..()-(- 18 8 0 1 0 0 1
Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy} Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy} ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy} E Et Eth Etho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ---[-----(-)] 13 8 0 1 0 0 1
phenyl)propanoic acid: phenyl)propanoic p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ):- 3 9 0 1 0 0 1
tabotropic glutamate tabotropic t ta tab tabo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ().....,, 9 8 0 1 0 0 1
2389-93. 2389-93. 2389-93. 2 23 238 2389 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 -. 2 1 0 1 0 0 1
[8] [8] [8] [ [8 [8] [8] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
de Paulis, de d de de de BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 0 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Baldwin, R.M., baldwin, B Ba Bal Bald BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..()- 14 9 0 1 0 0 1
(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on (1,3-diphenyl-1h-pyrazol-5-yl)benzamides ( (1 (1, (1,3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 (,-----) 8 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -... 4 9 0 1 0 0 1
Chem., 49, chem., C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,-. 5 2 0 1 0 0 1
[9] [9] [9] [ [9 [9] [9] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
De Vry, de D De De De BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 0 ,.,,.,,.() 10 9 0 1 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 () 2 9 0 1 0 0 1
BAY 36-7620. bay B BA BAY BAY BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 -....,,-. 9 5 0 1 0 0 1
[10] [10] [10] [ [1 [10 [10] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
El-Kouhen, O.; el-kouhen, E El El- El-K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -,.;,..,,..,,.,,..,,., 22 9 0 1 0 0 1
Hollingsworth, P.R., hollingsworth, H Ho Hol Holl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..,, 17 9 0 1 0 0 1
S.P., Uchic, s.p., S S. S.P S.P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ..,,..,,..,,..,,.,,.,, 22 9 0 1 0 0 1
M., Kolasa, m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.,,..,,..,,..,,..,- 22 9 0 1 0 0 1
land, R.B., land, l la lan land BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,..,,..,,.()- 13 9 0 1 0 0 1
sults in sults s su sul sult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :- 2 9 0 1 0 0 1
fects of fects f fe fec fect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -,-.. 5 9 0 1 0 0 1
J. Pharmacol., j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ..,,-. 6 3 0 1 0 0 1
[11] [11] [11] [ [1 [11 [11] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Galici, R., galici, G Ga Gal Gali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,..,,.,,.,,..,- 18 8 0 1 0 0 1
liams, L.C., liams, l li lia liam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,..()-, 14 9 0 1 0 0 1
allosteric modulator allosteric a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 9 0 1 0 0 1
antipsychotic-and anxiolytic-like antipsychotic-and a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 --....., 8 9 0 1 0 0 1
318, 173-85. 318, 3 31 318 318, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ,-. 3 1 0 1 0 0 1
[12] [12] [12] [ [1 [12 [12] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Gasparini, F., gasparini, G Ga Gas Gasp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,.,,.,,..,,.,, 17 9 0 1 0 0 1
I., Biollaz, i., I I. I., I., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.,,.,,.,,.,,.., 18 9 0 1 0 0 1
Johnson, E.C., johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..,,..,, 21 9 0 1 0 0 1
G., Kuhn, g., G G. G., G., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.()---()-(),, 16 9 0 1 0 0 1
selective and selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 8 0 1 0 0 1
cology, 38, cology, c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,,-. 4 2 0 1 0 0 1
[13] [13] [13] [ [1 [13 [13] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Goudet, C., goudet, G Go Gou Goud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,.,,.,,.,,.,-,., 19 9 0 1 0 0 1
Acher, F., acher, A Ac Ach Ache BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,.,,..() 11 9 0 1 0 0 1
glutamate receptor glutamate g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -.... 5 9 0 1 0 0 1
Sci. USA, sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,-. 5 2 0 1 0 0 1
[14] [14] [14] [ [1 [14 [14] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Goudet, C., goudet, G Go Gou Goud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Blahos, J., blahos, B Bl Bla Blah BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,.,,..() 11 9 0 1 0 0 1
metabotropic glutamate metabotropic m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 0 1 0 0 1
J. Biol. j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ...,,-. 7 3 0 1 0 0 1
[15] [15] [15] [ [1 [15 [15] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Govek, S.P., govek, G Go Gov Gove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,..,,.,, 15 8 0 1 0 0 1
J., Pracitto, j., J J. J., J., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.,,..,,..,,..,,..,, 22 9 0 1 0 0 1
B.A., Schaffhauser, b.a., B B. B.A B.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ..,,.,,..,,..,,.., 18 8 0 1 0 0 1
Vernier, J.M. vernier, V Ve Ver Vern BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..() 5 9 0 1 0 0 1
glutamate receptor glutamate g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ():- 4 9 0 1 0 0 1
nia. Bioorg. nia. n ni nia nia. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .....,,-. 9 5 0 1 0 0 1
[16] [16] [16] [ [1 [16 [16] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Hermans, E., hermans, H He Her Herm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,...(), 10 9 0 1 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 : 1 9 0 1 0 0 1
G-protein-coupled receptors. g-protein-coupled G G- G-p G-pr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 --...,,-. 9 6 0 1 0 0 1
[17] [17] [17] [ [1 [17 [17] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Higgins, G.A., higgins, H Hi Hig Higg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..,,..,, 21 9 0 1 0 0 1
G., Woltering, g., G G. G., G., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .,,.,,.,,.()- 13 9 0 1 0 0 1
lation of lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 0 1 0 0 1
Neuropharmacology, 46, neuropharmacology, N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,,-. 4 3 0 1 0 0 1
[18] [18] [18] [ [1 [18 [18] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Houamed, K.M., houamed, H Ho Hou Houa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..,,.., 20 9 0 1 0 0 1
Almers, W., almers, A Al Alm Alme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,.,,..()., 10 9 0 1 0 0 1
G protein-coupled g G G G G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 -.,,- 5 8 0 1 0 0 1
1321. 1321. 1321. 1 13 132 1321 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 . 1 0 0 1 0 0 1
[19] [19] [19] [ [1 [19 [19] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Johnson, M.P., johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,...,,..,,.., 20 8 0 1 0 0 1
Callagaro, D.O., callagaro, C Ca Cal Call BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..() 17 9 0 1 0 0 1
of allosteric of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 : 1 9 0 1 0 0 1
and subtype and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -(-(-))--(,,- 13 8 0 1 0 0 1
trifluoroethylsulfonyl)pyrid-3-ylmethylamine. J. trifluoroethylsulfonyl)pyrid-3-ylmethylamine. t tr tri trif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 )--....,,-. 11 9 0 1 0 0 1
[20] [20] [20] [ [2 [20 [20] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Johnson, M.P., johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..(),,,- 13 8 0 1 0 0 1
ston AE. ston s st sto ston BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .: 2 9 0 1 0 0 1
learnt from learnt l le lea lear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,.- 3 8 0 1 0 0 1
chem. Soc. chem. c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ...,,-. 7 3 0 1 0 0 1
[21] [21] [21] [ [2 [21 [21] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Johnson, M.P., johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,..,,.,,.., 18 8 0 1 0 0 1
Jagdmann, G.E., jagdmann, J Ja Jag Jagd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,..,,..,,..,, 17 8 0 1 0 0 1
D.D. (2005) d.d. D D. D.D D.D. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ..():- 6 9 0 1 0 0 1
lation, frequency-dependent lation, l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,-, 3 9 0 1 0 0 1
anxiety and anxiety a an anx anxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ().,,-. 7 7 0 1 0 0 1
[22] [22] [22] [ [2 [22 [22] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [] 2 0 0 1 0 0 1
Kinney, G.G., kinney, K Ki Kin Kinn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,',..,,.,,.,,..,, 20 9 0 1 0 0 1
M.K., Chen, m.k., M M. M.K M.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ..,,..,,..,,..,,..,,., 22 9 0 1 0 0 1
Jacobson, M.A., jacobson, J Ja Jac Jaco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ,..,,.,,..,,..,,..,- 20 8 0 1 0 0 1
liams, D.L. liams, l li lia liam BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,...()- 7 9 0 1 0 0 1
tabotropic glutamate tabotropic t ta tab tabo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 8 0 1 0 0 1
chotic-like effects chotic-like c ch cho chot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 -.....,, 8 9 0 1 0 0 1
199-206. 199-206. 199-206. 1 19 199 199- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -. 2 1 0 1 0 0 1
[23] [23] [23] [ [2 [23 [23] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Knoflach, F., knoflach, K Kn Kno Knof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,..,,.,,., 19 9 0 1 0 0 1
Wichmann, J., wichmann, W Wi Wic Wich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,..()- 9 8 0 1 0 0 1
tabotropic glutamate tabotropic t ta tab tabo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 :,, 3 9 0 1 0 0 1
binding site. binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .....,,-. 9 6 0 1 0 0 1
[24] [24] [24] [ [2 [24 [24] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Kolczewski, S., kolczewski, K Ko Kol Kolc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.,, 16 9 0 1 0 0 1
T. (1999) t. T T. T. T. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .()- 4 9 0 1 0 0 1
tabotropic glutamate tabotropic t ta tab tabo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 .....,,- 8 9 0 1 0 0 1
6. 6. 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 . 1 0 0 1 0 0 1
[25] [25] [25] [ [2 [25 [25] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Lavreysen, H., lavreysen, L La Lav Lavr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,., 15 9 0 1 0 0 1
Blokland, S., blokland, B Bl Blo Blok BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,...(), 16 9 0 1 0 0 1
highly potent, highly h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
Neuropharmacology, 47, neuropharmacology, N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,-. 4 3 0 1 0 0 1
[26] [26] [26] [ [2 [26 [26] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Levine, L., levine, L Le Lev Levi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Schoepp, D. schoepp, S Sc Sch Scho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.()/,, 7 8 0 1 0 0 1
anxiety induced anxiety a an anx anxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 9 0 1 0 0 1
der. Neuropharmacology, der. d de der der. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 .,,-. 5 4 0 1 0 0 1
[27] [27] [27] [ [2 [27 [27] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Lindsley, C.W., lindsley, L Li Lin Lind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,..,',..,,., 20 9 0 1 0 0 1
Williams, D.L. williams, W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,...,,.,,.,,..,,..,, 20 9 0 1 0 0 1
P.R., Smith, p.r., P P. P.R P.R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,.,,..,,..,,..,,..() 23 9 0 1 0 0 1
Discovery of discovery D Di Dis Disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
receptor subtype receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -(,----- 8 7 0 1 0 0 1
yl)benzamides that yl)benzamides y yl yl) yl)b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 )....,, 7 9 0 1 0 0 1
5825-8. 5825-8. 5825-8. 5 58 582 5825 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -. 2 0 0 1 0 0 1
[28] [28] [28] [ [2 [28 [28] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Litschig, S., litschig, L Li Lit Lits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,..,,., 19 9 0 1 0 0 1
Prezeau, L., prezeau, P Pr Pre Prez BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,...,,.,,.(),- 16 8 0 1 0 0 1
petitive metabotropic petitive p pe pet peti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,- 2 9 0 1 0 0 1
naling without naling n na nal nali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ...,,-. 7 8 0 1 0 0 1
[29] [29] [29] [ [2 [29 [29] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Maj, M., maj, M Ma Maj Maj, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.,, 16 9 0 1 0 0 1
W., Stoehr, w., W W. W., W., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .,,.,,.,,.,,.,,.,,., 20 9 0 1 0 0 1
Flor, P.J. flor, F Fl Flo Flor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..()(-)-,: 11 8 0 1 0 0 1
characterization, mechanism characterization, c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,,.- 4 8 0 1 0 0 1
cology, 45, cology, c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,-. 4 2 0 1 0 0 1
[30] [30] [30] [ [3 [30 [30] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Marino, M.J., marino, M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,.() 12 8 0 1 0 0 1
glutamate receptor glutamate g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 9 0 1 0 0 1
ous system. ous o ou ous ous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 .....,,-. 9 5 0 1 0 0 1
[31] [31] [31] [ [3 [31 [31] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Masu, M., masu, M Ma Mas Masu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.(). 17 9 0 1 0 0 1
Sequence and sequence S Se Seq Sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 .,, 3 9 0 1 0 0 1
760-765. 760-765. 760-765. 7 76 760 760- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -. 2 1 0 1 0 0 1
[32] [32] [32] [ [3 [32 [32] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Masugi, M., masugi, M Ma Mas Masu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.,- 16 8 0 1 0 0 1
sig, G., sig, s si sig sig, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.()- 11 9 0 1 0 0 1
ceptor subtype ceptor c ce cep cept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
taste aversion. taste t ta tas tast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ...,,-. 7 5 0 1 0 0 1
[33] [33] [33] [ [3 [33 [33] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Mathiesen, J.M., mathiesen, M Ma Mat Math BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,.,-,.,,.,, 15 9 0 1 0 0 1
M.T. (2003) m.t. M M. M.T M.T. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..()- 5 8 0 1 0 0 1
tamate receptor tamate t ta tam tama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ()-...., 8 8 0 1 0 0 1
138, 1026-30. 138, 1 13 138 138, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 ,-. 3 1 0 1 0 0 1
[34] [34] [34] [ [3 [34 [34] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Mitsukawa, K., mitsukawa, M Mi Mit Mits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Stoehr, N., stoehr, S St Sto Stoe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,..,,., 16 9 0 1 0 0 1
Cryan, J.F., cryan, C Cr Cry Crya BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..() 9 9 0 1 0 0 1
agonist: activation agonist: a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 : 1 10 0 1 0 0 1
parameters in parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .....,,-. 9 7 0 1 0 0 1
[35] [35] [35] [ [3 [35 [35] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Mitsukawa, K., mitsukawa, M Mi Mit Mits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.,,.,,.,,..,, 14 9 0 1 0 0 1
H., Flor, h., H H. H., H., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .,,..,,..() 11 9 0 1 0 0 1
ablation causes ablation a ab abl abla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 8 0 1 0 0 1
BDNF protein bdnf B BD BDN BDNF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 :-. 3 9 0 1 0 0 1
Neuropsychopharmacology, 31, neuropsychopharmacology, N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,-. 4 4 0 1 0 0 1
[36] [36] [36] [ [3 [36 [36] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Monn, J.A., monn, M Mo Mon Monn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,..,,..,,..,, 21 9 0 1 0 0 1
B.G., Howe, b.g., B B. B.G B.G. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,.,,..,,..,,..,,..,- 23 8 0 1 0 0 1
zano, J.P., zano, z za zan zano BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,..,,..(),- 19 9 0 1 0 0 1
thesis, and thesis, t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,()--[..] 9 9 0 1 0 0 1
hexane-2,6-dicarboxylic acid hexane-2,6-dicarboxylic h he hex hexa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -,-():,,- 9 9 0 1 0 0 1
tive group tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 9 0 1 0 0 1
sant and sant s sa san sant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ....,,-. 8 7 0 1 0 0 1
[37] [37] [37] [ [3 [37 [37] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
Monn, J.A., monn, M Mo Mon Monn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,..,,..,,..,, 21 9 0 1 0 0 1
J.P., Harkness, j.p., J J. J.P J.P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,..,,...,,..,,..,, 21 9 0 1 0 0 1
S.L., Kingston, s.l., S S. S.L S.L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,.,,.,,.,,..,,.., 20 9 0 1 0 0 1
Schoepp, D.D. schoepp, S Sc Sch Scho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..(),,- 8 8 0 1 0 0 1
lecular modeling lecular l le lec lecu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ()-- 4 7 0 1 0 0 1
aminobicyclo[3.1.0] hexane-2,6-dicarboxylic aminobicyclo[3.1.0] a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [..]-,-():- 11 8 0 1 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,, 2 9 0 1 0 0 1
II metabotropic ii I II II II BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ....,,-. 8 7 0 1 0 0 1
[38] [38] [38] [ [3 [38 [38] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
O'Brien, J.A., o'brien, O O' O'B O'Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ',..,,.,,..,,..,,..,, 21 8 0 1 0 0 1
S.N., Lindsley, s.n., S S. S.N S.N. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,..,,..,,.,,..,,.., 22 9 0 1 0 0 1
Williams, D.L. williams, W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,...() 6 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ...,,- 6 9 0 1 0 0 1
40. 40. 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 . 1 0 0 1 0 0 1
[39] [39] [39] [ [3 [39 [39] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 [] 2 0 0 1 0 0 1
O'Brien, J.A., o'brien, O O' O'B O'Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ',..,,.,,.,,..,,..,- 20 8 0 1 0 0 1
noski, D.D., noski, n no nos nosk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,..,,..,,..,,.,,.,, 19 9 0 1 0 0 1
M.E., Pettibone, m.e., M M. M.E M.E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ..,,..,,..,,...() 17 9 0 1 0 0 1
allosteric modulator allosteric a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
receptor subtype receptor r re rec rece BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .....,,-. 9 9 0 1 0 0 1
194 Current 194 1 19 194 194 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 ,,.,. 5 10 0 0 1 0 0
Gasparini and gasparini G Ga Gas Gasp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 0 1 0 0
[40] [40] [40] [ [4 [40 [40] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pagano, A., pagano, P Pa Pag Paga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Floersheim, P., floersheim, F Fl Flo Floe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,..,,.,,., 19 9 0 1 0 0 1
Flor, P.J., flor, F Fl Flo Flor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.()-- 13 9 0 1 0 0 1
methyl-6-(phenylethynyl)pyridine and methyl-6-(phenylethynyl)pyridine m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 --()-[]- 8 8 0 1 0 0 1
men-1a-carboxylic acid men-1a-carboxylic m me men men- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -- 2 9 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 .. 2 9 0 1 0 0 1
Biol. Chem., biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,,-. 6 3 0 1 0 0 1
[41] [41] [41] [ [4 [41 [41] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Parmentier, M.L., parmentier, P Pa Par Parm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.,,..() 15 9 0 1 0 0 1
functioning of functioning f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,,-. 7 8 0 1 0 0 1
[42] [42] [42] [ [4 [42 [42] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pecknold, J.C., pecknold, P Pe Pec Peck BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,.() 12 8 0 1 0 0 1
out-patients. Curr. out-patients. o ou out out- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -....,,-. 9 5 0 1 0 0 1
[43] [43] [43] [ [4 [43 [43] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pecknold, J.C., pecknold, P Pe Pec Peck BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,.,,.,,. 16 8 0 1 0 0 1
(1982) nt (1982) ( (1 (19 (198 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()()- 5 9 0 1 0 0 1
standard (diazepam) standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ()-...,, 8 9 0 1 0 0 1
9-33. 9-33. 9-33. 9 9- 9-3 9-33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 0 0 1 0 0 1
[44] [44] [44] [ [4 [44 [44] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pin, J.P., pin, P Pi Pin Pin, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,..,,.,,.(),, 13 9 0 1 0 0 1
mechanism of mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 /--..., 7 8 0 1 0 0 1
98, 325-54. 98, 9 98 98, 98, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-. 3 1 0 1 0 0 1
[45] [45] [45] [ [4 [45 [45] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pin, J.P., pin, P Pi Pin Pin, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,..,,.,,.,,.,,.,,.,,. 21 10 0 1 0 0 1
(2005) Allosteric (2005) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()--. 5 9 0 1 0 0 1
FEBS J., febs F FE FEB FEBS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,-. 5 2 0 1 0 0 1
[46] [46] [46] [ [4 [46 [46] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pinkerton, A.B., pinkerton, P Pi Pin Pink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,..,,..,, 17 8 0 1 0 0 1
H., Zhao, h., H H. H., H., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.,,..,,..() 14 9 0 1 0 0 1
the metabotropic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ().: 4 9 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -.....,, 8 9 0 1 0 0 1
5329-32. 5329-32. 5329-32. 5 53 532 5329 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 1 0 1 0 0 1
[47] [47] [47] [ [4 [47 [47] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pinkerton, A.B., pinkerton, P Pi Pin Pink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,..,,..,,.., 20 9 0 1 0 0 1
Schaffhauser, H., schaffhauser, S Sc Sch Scha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,..,,..() 16 9 0 1 0 0 1
potentiators of potentiators p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ().:- 5 8 0 1 0 0 1
thiopyridyl acetophenones thiopyridyl t th thi thio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -- 2 9 0 1 0 0 1
tiators. Bioorg. tiators. t ti tia tiat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .....,,-. 9 5 0 1 0 0 1
[48] [48] [48] [ [4 [48 [48] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Pinkerton, A.B., pinkerton, P Pi Pin Pink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,..,,..,,.., 20 9 0 1 0 0 1
Rowe, B.A., rowe, R Ro Row Rowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,..,,..,, 16 8 0 1 0 0 1
L.P., Vernier, l.p., L L. L.P L.P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,,..()- 9 9 0 1 0 0 1
mate receptor mate m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ().:- 5 9 0 1 0 0 1
danone containing danone d da dan dano BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ....., 6 8 0 1 0 0 1
15, 1565-71. 15, 1 15 15, 15, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-. 3 1 0 1 0 0 1
[49] [49] [49] [ [4 [49 [49] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Porter, R.H., porter, P Po Por Port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,..,,.,,.,,..,,., 17 8 0 1 0 0 1
Kolczewski, S., kolczewski, K Ko Kol Kolc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,.,,.,,.,- 17 9 0 1 0 0 1
mann, A., mann, m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.(): 14 9 0 1 0 0 1
validated nonbenzodiazepine validated v va val vali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,- 3 9 0 1 0 0 1
petitive mGlu5 petitive p pe pet peti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..- 3 9 0 1 0 0 1
col. Exp. col. c co col col. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,,-. 7 3 0 1 0 0 1
[50] [50] [50] [ [5 [50 [50] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Ritzen, A., ritzen, R Ri Rit Ritz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,.() 11 8 0 1 0 0 1
and therapeutic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
modulators. Basic modulators. m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,,-. 8 6 0 1 0 0 1
[51] [51] [51] [ [5 [51 [51] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 [] 2 0 0 1 0 0 1
Rodriguez, D., rodriguez, R Ro Rod Rodr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,..,,., 16 8 0 1 0 0 1
Campbell, U. campbell, C Ca Cam Camp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.()-- 6 8 0 1 0 0 1
sponses in sponses s sp spo spon BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
receptor 2 receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 [],- 4 9 0 1 0 0 1
nual Meeting nual n nu nua nual BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..,, 4 9 0 1 0 0 1
TX. Society tx. T TX TX. TX. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .,,. 4 5 0 1 0 0 1
[52] [52] [52] [ [5 [52 [52] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Romano, C., romano, R Ro Rom Roma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,..,',..() 13 8 0 1 0 0 1
receptor 5 receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -....,,-. 9 9 0 1 0 0 1
[53] [53] [53] [ [5 [53 [53] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Rorick-Kehn, L.M., rorick-kehn, R Ro Ror Rori BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 -,..,,..,,..,,..,, 18 9 0 1 0 0 1
D.O., Marek, d.o., D D. D.O D.O. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ..,,..,,..,,..,,..,, 20 9 0 1 0 0 1
D.D., Herin, d.d., D D. D.D D.D. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ..,,..,,..,,..,,..() 20 8 0 1 0 0 1
Pharmacological and pharmacological P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 -,- 3 9 0 1 0 0 1
tent, selective tent, t te ten tent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ,/: 3 8 0 1 0 0 1
LY404039. J. ly404039. L LY LY4 LY40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .....,,-. 9 6 0 1 0 0 1
[54] [54] [54] [ [5 [54 [54] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Schoepp, D.D., schoepp, S Sc Sch Scho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,..,,..,,..() 13 9 0 1 0 0 1
at subtypes at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .,, 3 9 0 1 0 0 1
1431-76. 1431-76. 1431-76. 1 14 143 1431 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 -. 2 1 0 1 0 0 1
[55] [55] [55] [ [5 [55 [55] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Shipe, W.D., shipe, S Sh Shi Ship BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,..,,..,,...,,..() 18 9 0 1 0 0 1
Recent advances recent R Re Rec Rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
receptors. Curr. receptors. r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .....,,-. 9 6 0 1 0 0 1
[56] [56] [56] [ [5 [56 [56] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Sladeczek, F., sladeczek, S Sl Sla Slad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,..,,.,,.,,.()- 18 9 0 1 0 0 1
mate stimulates mate m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .,, 3 10 0 1 0 0 1
717-719. 717-719. 717-719. 7 71 717 717- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -. 2 1 0 1 0 0 1
[57] [57] [57] [ [5 [57 [57] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Slassi, A., slassi, S Sl Sla Slas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,.,,.,,.,,., 18 9 0 1 0 0 1
Nilsson, K., nilsson, N Ni Nil Nils BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,.,,..,,.., 17 9 0 1 0 0 1
Johnson, E. johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.()-- 6 9 0 1 0 0 1
tagonists and tagonists t ta tag tago BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ....., 6 10 0 1 0 0 1
5, 897-911. 5, 5 5, 5, 5, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ,-. 3 1 0 1 0 0 1
[58] [58] [58] [ [5 [58 [58] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Spooren, W., spooren, S Sp Spo Spoo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,.,,.,,.,,. 17 10 0 1 0 0 1
(2003) Insight (2003) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ()- 3 9 0 1 0 0 1
mate (mGlu) mate m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 (): 3 9 0 1 0 0 1
treatment of treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ...,,-. 7 7 0 1 0 0 1
[59] [59] [59] [ [5 [59 [59] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Spooren, W., spooren, S Sp Spo Spoo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.(): 8 9 0 1 0 0 1
of anxiolytics? of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ?.,,-. 6 6 0 1 0 0 1
[60] [60] [60] [ [6 [60 [60] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Steckler, T., steckler, S St Ste Stec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,..,,.,, 14 9 0 1 0 0 1
H., Prickaerts, h., H H. H., H., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .,,.,,.,,..() 13 9 0 1 0 0 1
blockade on blockade b bl blo bloc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -.- 3 9 0 1 0 0 1
chopharmacology, 179, chopharmacology, c ch cho chop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ,,-. 4 3 0 1 0 0 1
[61] [61] [61] [ [6 [61 [61] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Steckler, T., steckler, S St Ste Stec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,..,,.,,.,, 14 9 0 1 0 0 1
A.M., Langlois, a.m., A A. A.M A.M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ..,,.,,..,,.()- 15 9 0 1 0 0 1
mate receptor mate m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
maze task. maze m ma maz maze BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ...,,-. 7 5 0 1 0 0 1
[62] [62] [62] [ [6 [62 [62] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Valenti, O., valenti, V Va Val Vale BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,..,,..,,..() 19 9 0 1 0 0 1
Group III group G Gr Gro Grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 --- 3 9 0 1 0 0 1
tory transmission tory t to tor tory BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 11 6 - 1 9 0 1 0 0 1
rons. J. rons. r ro ron rons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .....,,-. 9 5 0 1 0 0 1
[63] [63] [63] [ [6 [63 [63] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 [] 2 0 0 1 0 0 1
Wichmann, J., wichmann, W Wi Wic Wich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,,.,,.,,.,,.() 16 9 0 1 0 0 1
Structure-activity relationships structure-activity S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 --[,-] 6 9 0 1 0 0 1
as group as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .... 4 9 0 1 0 0 1
Lett., 9, lett., L Le Let Lett BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .,,-. 5 2 0 1 0 0 1
Received: February received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 :, 2 10 0 1 0 0 1
Accepted: April accepted: A Ac Acc Acce BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 :, 2 8 0 1 0 0 1

